Genetic Variation in CYP2R1 and GC Genes Associated with Vitamin D Deficiency Status

Journal of Pharmacy Practice

Volumn 30, Issue 1, 2017, Pages 31-36

  Slater, Nicole A ^a   Rager, Michelle L ^b   Havrda, Dawn E ^b   Harralson, Arthur F ^b  

^a AUBURN UNIVERSITY   (United States)

^b SHENANDOAH UNIVERSITY   (United States)

Author keywords

deficiency; genetics; rs10741657; rs12785878; rs2228570; rs2282679; Vitamin D

Indexed keywords

7 DEHYDROCHOLESTEROL REDUCTASE; CALCIFEDIOL; CYTOCHROME P450; CYTOCHROME P450 2R I; GENOMIC DNA; PEPTIDES AND PROTEINS; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D BINDING PROTEIN; VITAMIN D RECEPTOR; 25-HYDROXYVITAMIN D; 7-DEHYDROCHOLESTEROL REDUCTASE; CALCITRIOL RECEPTOR; CHOLESTANETRIOL 26 MONOOXYGENASE; CYP2R1 PROTEIN, HUMAN; CYTOCHROME P450 FAMILY 2; OXIDOREDUCTASE; VDR PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET SUPPLEMENTATION; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; REAL TIME POLYMERASE CHAIN REACTION; VITAMIN D DEFICIENCY; ALLELE; ANALOGS AND DERIVATIVES; BLOOD; GENETIC PREDISPOSITION; GENETICS;

AGED; ALLELES; CHOLESTANETRIOL 26-MONOOXYGENASE; CROSS-SECTIONAL STUDIES; CYTOCHROME P450 FAMILY 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; RECEPTORS, CALCITRIOL; VITAMIN D; VITAMIN D DEFICIENCY; VITAMIN D-BINDING PROTEIN;

EID: 85011362795     PISSN: 08971900     EISSN: 15311937     Source Type: Journal    
DOI: 10.1177/0897190015585876     Document Type: Article

References (31)

1. Holick M,. Vitamin D deficiency. N Engl J Med. 2007; 357 (3): 266-281.
2. Haines S, Park SK,. Vitamin D supplementation: what's known, what to do, and what's needed. Pharmacotherapy. 2012; 32 (4): 354-382.
3. The National Osteoporosis Foundation. Vitamin D and Bone Health. February 2012. Available from: http://nof.org/files/nof/public/content/clinicalupdates/clinicalupdates/Issue25VitaminD/2012-VitaminD.html. Accessed May 9, 2015.
4. Giovannucci E,. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States.). Cancer Causes Control. 2005; 16 (2): 83-95.
5. Ma Y, Zhang P, Wang F, et al. Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J Clin Oncol. 2011; 29 (28): 3775-3782.
6. Lappe JM, Travers-Gustafson D, Davies KM, et al. Vitamin D and calcium supplementation reduce cancer risk: results of a randomized trial. Am J Clin Nutr. 2007; 85 (6): 1586-1591.
7. Giovannucci E, Liu Y, Hollis BW, et al. 25-Hydroxyvitamin D and risk of myocardial infarction in men. Arch Intern Med. 2008; 168 (11): 1174-1180.
8. Brondum-Jacobsen P, Benn M, Jensen GB, et al. 25-Hydroxyvitamin D levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analyses of 18 and 17 studies. Arterioscler Thromb Vasc Biol. 2012; 32 (11): 2794-2802.
9. Wang TJ, Pencina MJ, Booth SJ, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008; 117 (4): 503-511.
10. Levin GP, Robinson-Cohen C, Boer IH, et al. Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes. JAMA. 2012; 308 (18): 1898-1905.
11. De Boer IH, Levin GP, Robinson-Cohen C, et al. Serum 25-hydroxyvitamin D concentration and risk for major clinical disease events in a community-based population of older adults: a cohort study. Ann Intern Med. 2012; 156 (9): 627-634.
12. Autier P, Gandini S,. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007; 167 (16): 1730-1737.
13. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guidelines. J Clin Endocrinol Metab. 2011; 96 (7): 1911-1930.
14. 3 in humans. J Clin Endocrinol Metab. 2004; 89 (11): 5387-5391.
15. Shea MK, Benjamin EL, Dupuis J, et al. Genetic and non-genetic correlates of vitamins K and D. Eur J Clin Nutr. 2009; 63 (4): 458-464.
16. Engelman CD, FIngerlin TE, Langefeld CD, et al. Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. J Clin Endocrinol Metab. 2008; 93 (9): 3381-3388.
17. Hussein AG, Mohamed RH, Alghobashy AA,. Synergism of CYP2R1 and CYP27B1 polymorphisms and susceptibility to type 1 diabetes in Egyptian children. Cell Immunol. 2012; 279 (1): 42-45.
18. Cheng JB, Levine MA, Bell NH, et al. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci U S A. 2004; 101 (20): 7711-7715.
19. Engelman CD, Meyers KJ, Iyengar SK, et al. Vitamin D intake and season modify the effects of the GC and CYP2R1 genes on 25-hydroxyvitamin D concentrations. J Nutr. 2013; 143 (1): 17-26.
20. Koo G, Conley SK, Wassif CA, et al. Discordant phenotype and sterol biochemistry in Smith-Lemli-Opitz syndrome. Am J Med Genet A. 2010; 152A (8): 2094-2098.
21. Ahn J, Yu K, Stolzenberg-Solomon R, et al. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet. 2010; 19 (13): 2739-2745.
22. Perna L, Felix JF, Breitling LP, et al. Genetic variations in the vitamin D binding protein and season-specific levels of vitamin D among older adults. Epidemiology. 2013; 24 (1): 104-109.
23. Wang TJ, Zhang F, Richards JB, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet. 2010; 376 (9736): 180-188.
24. Trabert B, Malone KE, Dalling JR, et al. Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women. Breast Cancer Res. 2007; 9 (6): R84.
25. Grant DJ, Hoyo C, Akushevic L, et al. Vitamin D receptor (VDR) polymorphisms and risk of ovarian cancer in Caucasian and African American women. Gynecol Oncol. 2013; 129 (1): 173-178.
26. Zeljic K, Supic G, Stamenkovic Radak M, et al. Vitamin D receptor, CYP27B1 and CYP24A1 genes polymorphisms association with oral cancer risk and survival. J Oral Pathol Med. 2012; 41 (10): 779-787.
27. Sinotte M, Diorio C, Berube S, et al. Genetic polymorphisims of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women. Am J Clin Nutr. 2009; 89 (2): 634-640.
28. Bischof MG, Heinze G, Vierhapper H,. Vitamin D status and its relation to age and body mass index. Horm Res. 2006; 66 (5): 211-215.
29. Arunabh S, Pollack S, Yeh J, et al. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab. 2003; 88 (1): 157-161.
30. Lagunova Z, Porojicu AC, Lindberg F, et al. The dependency of vitamin D status on body mass index, gender, age, and season. Anticancer Res. 2009; 29 (9): 3713-3720.
31. Holick MF, Matsuoka LY, Wortsman J,. Age, vitamin D, and solar ultraviolet. Lancet. 1989; 2 (8671): 1104-1105.